JP3 enhances the toxicity of cisplatin on drug-resistant gastric cancer cells while reducing the damage to normal cells

Conclusions: JP3 enhanced the inhibitory effects of DDP on tumor growth while reduced toxic side effects of DDP on normal cells. The results of this study provide a new insight for the treatment of drug-resistant GC.

Source: Journal of Cancer - April 19, 2021 Category: Cancer & Oncology Authors: Yi Zhang, Junjie Chen, Zhen Che, Chuanjun Shu, Dongyin Chen, Kun Ding, Aiping Li, Jianwei Zhou Tags: Research Paper Source Type: research